# Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

> **NCT01646385** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 6393 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** etanercept
- **DRUG:** non-biologic anti-rheumatic drugs

## Key facts

- **NCT ID:** NCT01646385
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 6393 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646385, "Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01646385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*